World Hemophilia Day Observed in Bhubaneswar; Advanced Treatment Facilities Introduced in Odisha
Bhubaneswar, 17 April (H.S.): World Hemophilia Day was observed at the Hemophilia Day-Care Centre located at Capital Hospital and PGIMER, Bhubaneswar, with a focus on enhancing awareness and strengthening treatment facilities for patients in Odisha
World Hemophilia Day Observed


Bhubaneswar, 17 April (H.S.): World Hemophilia Day was observed at the Hemophilia Day-Care Centre located at Capital Hospital and PGIMER, Bhubaneswar, with a focus on enhancing awareness and strengthening treatment facilities for patients in Odisha.

On the occasion, improved medical services and new treatment options were introduced, marking a significant step toward better care for hemophilia patients in the state.

Odisha’s Health and Family Welfare Minister Mukesh Mahaling attended the event as the chief guest. He reaffirmed the state government’s commitment to supporting hemophilia patients, highlighting initiatives such as free treatment, availability of clotting factors, and awareness programmes across Odisha.

Observed annually on April 17, World Hemophilia Day aims to raise awareness about this rare genetic disorder. This year’s theme, “Diagnosis: First Step to Care,” emphasizes the importance of early detection and timely treatment.

Hemophilia is a hereditary disorder in which the blood does not clot properly due to the deficiency or absence of clotting factors. As a result, even minor injuries can lead to prolonged bleeding, and in some cases, internal bleeding may occur, posing serious health risks. The condition not only affects patients but also places a significant burden on their families.

The Minister announced that Non-Factor Therapy, an advanced and more effective treatment method, will soon be made available in the state. This therapy is expected to significantly reduce the risk of recurrent bleeding episodes, enabling patients to lead healthier and more normal lives.

In a major development, Odisha has introduced Extended Half-Life Factor VIII and Von Willebrand Factor therapies for the first time. These modern treatment options are designed to reduce the frequency of injections, improve patients’ quality of life, and allow them greater independence.

Senior officials, including the Director of Capital Hospital and PGIMER, Director and Additional Director of the Blood Safety Department, Superintendent and Deputy Superintendent of Capital Hospital, the Principal of PGIMER, and representatives from the Hemophilia Society, were present at the event.

---------------

Hindusthan Samachar / Monalisa Panda


 rajesh pande